| Similar Articles |
|---|
 |
Chemistry World
September 2, 2013
Emma Stoye |
Endo Health to buy Boca Pharmacal for $225m US speciality healthcare company Endo Health Solutions has agreed to buy Boca Pharmacal for $225 million in a bid to expand its generics business.   |
Pharmaceutical Executive
October 1, 2011 |
30 Years of Pharma: Perspective in Numbers, Part 3 Top 10 generics companies. |
Pharmaceutical Executive
October 1, 2010 |
Taking a Less-Generic Route to Generics A leading pharmaceutical industry player speaks out on what is fueling success in the sector. |
Chemistry World
October 14, 2013
Phillip Broadwith |
5000 jobs to be cut at Teva Israeli generics heavyweight Teva is accelerating its previously announced costcutting drive. |
Managed Care
January 2007
Martin Sipkoff |
Employers Want Plans & PBMs To Push Hard for Generics Health insurers' aggressive stand on members' use of generic drugs can attract new clients, but does it interfere with the physician-patient relationship? |
Finance & Development
September 1, 2007
Salyer & Bloom |
The March of the Cities The coming year marks a dramatic milestone: the world's urban population will outstrip its rural population, albeit with big regional variations. |
The Motley Fool
October 4, 2004
Tom Taulli |
Cytec Doubles Down on Chemicals The leading specialty chemical products company spends the big bucks on an acquisition that will double its annual revenues. While the acquisition looks good on paper, it is still a huge undertaking with enough inherent risk to make investors jittery. |
Chemistry World
May 21, 2009
Matt Wilkinson |
Big Pharma set for generics boost Pharmaceutical firms have been rushing to ensure they minimize their losses by expanding their generics businesses and reach into emerging markets. |
